ANTONIO
PORTOLÉS PÉREZ
Profesor titular de universidad
Mikel
Temprano Gocenola
Mikel Temprano Gocenola-rekin lankidetzan egindako argitalpenak (1)
2021
-
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
The Lancet, Vol. 398, Núm. 10295, pp. 121-130